Comparing Efficacy and Safety of TJO-083 in Dry Eye Disease Patients

A Phase 1/2. Multicenter, Randomized, Double-blinded, Placebo and Active-controlled, Parallel Study for Comparing Efficacy and Safety of TJO-083 in Dry Eye Disease Patients

This is a prospective randomized study compared with active control and placebo arms.

Inclusion Criteria:

• Male or female, age 20 or over
• Patient who have been diagnosed with dry eye syndrome at least 6 months ago
• Screening both eyes, the corrected visual acuity is 0.2 or more
• Written informed consent to participate in the trial

Exclusion Criteria:

• Screening visits within 2 months the patients with systemic or ocular disorders affected the test results (ocular surgery, trauma, or disease)
• Intraocular pressure(IOP)> 21 mmHg